Lennox Completes Acquisition of NSI Industries' HVAC Division
Get Alerts LII Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1%
Revenue Growth %: +9.8%
Join SI Premium – FREE
Lennox expands HVAC parts and supplies portfolio with the DuroDyne and Supco brands to better serve residential and commercial customers
"This acquisition enhances our ability to support residential and commercial customers throughout the entire HVAC value chain," said
Maskara added, "We are excited to welcome the Duro Dyne and Supco teams to Lennox. Our shared values will help us to integrate seamlessly to further enhance our ability to deliver comprehensive lifecycle solutions to our customers. By strengthening our distribution capabilities and broadening our product portfolio, we're positioning Lennox to deliver greater value across the full customer journey from equipment and installation to service and preventative maintenance. This transaction reflects our disciplined approach to strategic investment and long-term growth."
Lennox (NYSE: LII) is a leader in energy-efficient climate-control solutions. We are committed to sustainability and creating comfortable, healthier environments for residential and commercial customers. Our innovative portfolio includes cooling, heating, indoor air quality, and refrigeration systems, along with a comprehensive range of HVAC parts, supplies, and services that support the full lifecycle of customer needs. Additional information is available at www.lennox.com. For media inquiries, contact [email protected].
View original content to download multimedia:https://www.prnewswire.com/news-releases/lennox-completes-acquisition-of-nsi-industries-hvac-division-302585884.html
SOURCE Lennox International Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bottle Nexus, The Leading Direct-To-Consumer Alcohol Compliance and Checkout Platform, Sees Tremendous Company Growth Across Organization; Growing at a YOY growth of over 25%, Securement of Over 500 A
- Accelerate Regulatory Writing with Gen-AI Without Prompt Engineering, Upcoming Webinar Hosted by Xtalks
- FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share